Showing results (21-30 of 497) with videos related to
Sort By:
Pageof 50
Future Oncology (London, England)|May 10, 2017
Clinical development of CT-P10 and other biosimilar cancer therapeuticsWon Seog Kim, Bertrand Coiffier, Hyuk-Chan Kwon, et al.Journal of Cancer|April 15, 2021
Impact of transformation on the survival of patients diagnosed with follicular lymphoma that progressed within 24 monthsSang Eun Yoon, Junhun Cho, Won Seog Kim, et al.Leukemia Research|June 5, 2012
Rad knockdown induces mitochondrial apoptosis in bortezomib resistant leukemia and lymphoma cellsSeon-Yong Yeom, Sook-Ja Lee, Won Seog Kim, et al.The American Journal of Dermatopathology|July 3, 2010
Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical courseSanghui Park, Dong-Youn Lee, Won Seog Kim, et al.Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesisChaehwa Park, Won-Seog Kim, Yunseon Choi, et al.Blood Research|October 3, 2013
Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working PartyCheolwon Suh, Won Seog Kim, Jin Seok Kim, et al.Hematological Oncology|September 6, 2021
Comparison of first-line treatments of peripheral T-cell lymphoma according to regimen: A systematic review and meta-analysisJinchul Kim, Jinhyun Cho, Seonggyu Byeon, et al.Current Opinion in Oncology|August 11, 2015
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and updateJung Yong Hong, Young Hyeh Ko, Seok Jin Kim, et al.Cancer Research and Treatment|December 4, 2009
Treatment outcome of limited stage Hodgkin's diseaseJung Hun Kang, Yong Chan Ahn, Won Seog Kim, et al.Blood Research|June 30, 2020
Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective studyJoon Young Hur, Sang Eun Yoon, Seok Jin Kim, et al.Pageof 50